Malik, Mannat
$105,000.00 CAD
- Department
- Canadian Institutes of Health Research
- Program
- Research in Priority Areas
- Recipient country
- United States
- Fiscal year
- 2022-2023
- Agreement period
- May 1, 2022 – April 30, 2025
- Reference
- cihr-irsc:236-2022-2023-Q1-01063
Published purpose
• The CIHR HIV/AIDS Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI (as identified in the Public Health Agency of Canada’s pan-Canadian STBBI framework for action). This includes, but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR Research Themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research. • Research that focuses on key populations identified by Canada’s pan-Canadian STBBI framework for action is highly encouraged.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.